Cinacalcet Tablet, Film Coated
Product Images NDC 63629-9607

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Cinacalcet (NDC 63629-9607). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cinacalcet-fig3 (Cinacalcet Fig3)

A line graph depicting calcium levels (mg/dL) over time in weeks for patients with parathyroid carcinoma. The x-axis represents weeks from baseline (B) to 80 weeks, covering titration and maintenance phases. The y-axis shows calcium levels from 8 to 16 mg/dL with data points plotted along with error bars.*

FDA Label Image

Cinacalcet-fig4.jpg (Cinacalcet Fig4)

A line graph depicting calcium levels (mg/dL) over time in weeks during titration and maintenance phases, including error bars. The x-axis shows weeks from baseline to week 80, and the y-axis shows calcium concentration ranging from 8 to 15 mg/dL. Data points are marked with sample sizes (intractable pHPT) at the bottom.*

FDA Label Image

Cinacalcet-figure-1.jpg (Cinacalcet Figure 1)

A line graph titled 'Mean (SE) iPTH Values (Pooled Phase 3 Studies)' comparing iPTH levels (pg/ml) over 26 weeks between placebo and Cinacalcet treatment groups. The y-axis shows iPTH levels ranging from 0 to 1000 pg/ml, and the x-axis represents weeks from 0 to 26. Cinacalcet shows a decreasing trend in iPTH values over time, whereas placebo values remain relatively stable, each with error bars indicating standard error.*

FDA Label Image

Cinacalcet-figure-2 (Cinacalcet Figure 2)

A line graph titled 'Mean (SE) Ca x P Values (Pooled Phase 3 Studies)' showing the changes in calcium-phosphorus product levels (mg/dL) over 26 weeks. It compares two groups: placebo indicated by a dashed line, and Cinacalcet represented by a solid line. The graph shows mean values with standard error bars across weekly intervals.*

FDA Label Image

Cinacalcet-str (Cinacalcet Str)

Chemical structure of Cinacalcet hydrochloride shown as a molecular diagram with labeled rings, trifluoromethyl group, and hydrochloride (HCl) component.*

FDA Label Image

Label (Lbl636299607)

Label for Cinacalcet Tablets 60 mg film-coated oral tablets by Bryant Ranch Prepack. The label includes the NDC 63629-9607-1, instructions for storage at 25°C with permitted excursions, and dispensing in light-resistant containers. The package contains 30 tablets and is marked Rx only. The label features the BRP Pharmaceuticals logo in red and blue.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.